India's Satwiksairaj Rankireddy and Chirag Shetty progressed to the second round of the Indonesia Masters, defeating opponents from Chinese Taipei. Tanisha Crasto also advanced in mixed doubles ...
Satwiksairaj Rankireddy and Chirag Shetty will take on Malaysian Sze Fei Goh and Nur Izzuddin in the men's doubles second semi-final of the Indian Open 2025 at Indira Gandhi Indoor Stadium ...
Catalyst Pharmaceuticals (CPRX) reported that its sub-licensee in Japan, DyDo Pharma has launched FIRDAPSE Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living ...
Royalty Pharma (RPRX) announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its external manager, RP Management. This transaction to simplify ...
Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda ...
Satwiksairaj Rankireddy and Chirag Shetty stayed on course to go one better on their runner-up finish last year with a comprehensive 21-10, 21-17 win against Korea’s Yong Jin and Kang Min Hyu ...
On Saturday, the seventh-seeded Indian duo was defeated by South Korea's Kim Won-ho and Seo Seung-Jae 10-21, 15-21 in a rather one-sided match within 40 minutes, bringing an end to the Indian ...
Cash balance of the liquidity account: €8,943.42. In the reporting period, interest on the cash balance was received in the amount of €133.68. As a reminder as reported on August 12, 2024, the ...
Purdue Pharma owners could pay $7.4 billion in new settlement to lawsuits over the toll of OxyContin
Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...
Years of scouring the bush and breeding work at The University of Queensland have resulted in new varieties of a native Australian plant valuable to the global pharmaceutical industry ...
Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller, New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback